logo transparent gif
top_white_spacer
Home Latest Stock Forum Topics MyCorner - Personal Stocks Porfolio Stock Lists Investor Insights Investor Research & Links Dynamic Stock Charting FREE Registration About Us top spacer top spacer
 User Password Auto-Login
Enter Stock
 
righttip
branding

Back
First   < Newer   421-440 of 4174   Older>   Last  
Latest Forum Topics / EFH Ltd    Last:0.051 --  Post Reply
BIO PHARMA company do research on MEDICAL DISEASES
StevenLow
Member
27-Nov-2020 15:07     
 
StevenLow About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		And 1 more thing about Nasdaq listing...zipped.. They recently March 2020 done $3.1m placement shares for expansion..Biolidics is listed on December 2019 @$0.28.now doing business world wide...
 Useful To Me  Not Useful To Me
StevenLow
Member
27-Nov-2020 14:52     
 
StevenLow About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Not many company doing this proprietary antigen test kits in Singapore. Only licensed company like biolidics who do cancer diagnostic separating cancer cell from good blood cells..can do this. And Biolidics is chosen by HSA to do this test for all entry points in Singapore 🇸 🇬 ..just read up all the Biolidics news..by the way, I spoken to the representative 2 Times.. they also partnership with AStar for the new serology test kits...Biolidics test kits will be used in hospitals and clinics..Read the latest HSA news..
 Useful To Me  Not Useful To Me


Cadence88
Veteran
27-Nov-2020 13:32     
 
Cadence88 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		How do you know all checkpoints will use their test kits ? 

StevenLow      ( Date: 27-Nov-2020 12:45) Posted:

1st half ending 30/6/2020 FS, Biolidics made $6 million profit from antibody test kits alone, since corvic-19 started in March 2020, they had invested heavily and manufactures antibody test kits.Biolidics proprietor test kits is been sold in US,China,Vietnam,EU,Hongkong and Singapore.and now in Indonesia...they had  sold these proprietary test kits all the while, please read company news & do your own maths before putting your money on this stock...I think today will exceed $0.40...because all check points will use this test kits approved by HSA.
 Useful To Me  Not Useful To Me
lailai
Elite
27-Nov-2020 13:04     
 
lailai About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Based on the points u posted, think by 2H result time, shd easily reach 60-80c.
Patience needed if want more than just 40c. Think if tdy cannot break 40, next week likely.
Just opinion.laughFuture looks good for Bio, esp now with approval given by authority in Indonesia, as this country is the worst hit in SEA.
 

StevenLow      ( Date: 27-Nov-2020 12:45) Posted:

1st half ending 30/6/2020 FS, Biolidics made $6 million profit from antibody test kits alone, since corvic-19 started in March 2020, they had invested heavily and manufactures antibody test kits.Biolidics proprietor test kits is been sold in US,China,Vietnam,EU,Hongkong and Singapore.and now in Indonesia...they had  sold these proprietary test kits all the while, please read company news & do your own maths before putting your money on this stock...I think today will exceed $0.40...because all check points will use this test kits approved by HSA.
 Useful To Me  Not Useful To Me
Joelton
Supreme
27-Nov-2020 13:01     
 
Joelton About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin
Biolidics' Covid-19 test kits to be distributed and used in Indonesia
 
CATALIST-LISTED medtech firm Biolidics on Thursday said its Covid-19 antibody test kits had, on Wednesday, obtained authorisation from the Indonesian health authorities for distribution and use in Indonesia.
 
The authorisation remains valid until Nov 25, 2021. The validity period may be extended " should there be no undesirable events upon usage" , Biolidics said.
 
The company noted that results from the test kits are not to be used for confirmatory testing or as the sole basis for diagnosis. The results have to be interpreted together with clinical presentation and are to be confirmed with supplementary testing.
 
It said shareholders and potential investors should note that policies relating to the diagnosis and detection of the Covid-19 virus and antibodies in various jurisdictions may change in response to developments in the Covid-19 situation, which is evolving rapidly.
 Useful To Me  Not Useful To Me


StevenLow
Member
27-Nov-2020 12:45     
 
StevenLow About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		1st half ending 30/6/2020 FS, Biolidics made $6 million profit from antibody test kits alone, since corvic-19 started in March 2020, they had invested heavily and manufactures antibody test kits.Biolidics proprietor test kits is been sold in US,China,Vietnam,EU,Hongkong and Singapore.and now in Indonesia...they had  sold these proprietary test kits all the while, please read company news & do your own maths before putting your money on this stock...I think today will exceed $0.40...because all check points will use this test kits approved by HSA.
 Useful To Me  Not Useful To Me
Starship
Supreme
27-Nov-2020 12:21     
 
Starship About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin

eric998      ( Date: 27-Nov-2020 10:07) Posted:

wait for ordesr and sales figures.. all these are paper news.. need to see real money coming in.. talk is free.. trade with care..

WBdisciple      ( Date: 27-Nov-2020 09:20) Posted:

TOTAL OF TWO ANNOUNCEMENTS last night by Biolidics 
https://www.biolidics.com/announcements
 
First one:  Biolidics&rsquo COVID-19 Antibody Test Kits obtained the relevant authorisation from Kementerian Kesehatan Republik Indonesia, which is the Ministry of Health in Indonesia, for it to be distributed and used in Indonesia  (the " Authorisation" ). The Authorisation remains valid until 25 November 2021 and the extension of its validity may be permissible should there be no undesirable events upon usage.
 
Second one:  Biolidics entered into a distribution agreement (the " JOYSBIO Agreement" ) with JOYSBIO (Tianjin) Biotechnology Co, Ltd,  a company incorporated in Tianjin, the People' s Republic of China (" JOYSBIO" ). JOYSBIO is the product owner of the medical device known as the  " SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold)"
 
Under the terms of the JOYSBIO Agreement, the Company has been appointed as the non-exclusive worldwide distributor of the JOYSBIO Antigen Rapid Test Kit for a duration of one year from the date of the JOYSBIO Agreement. In addition, under the terms of the JOYSBIO Agreement, among others, the Company shall automatically become the exclusive distributor of the JOYSBIO Antigen Rapid Test Kit in Singapore and the Philippines if the number of kits ordered by the Company reaches 100,000 units within 90 calendar days in Singapore and 1,000,000 units within 180 calendar days in the Philippines, from the date of the JOYSBIO Agreement (i.e. 26 November 2020), respectively.
 
The Company was appointed by JOYSBIO to prepare and submit applications to the Health Sciences Authority (" HSA" ) for provisional authorisation of the JOYSBIO Antigen Rapid Test Kit in Singapore (" Provisional Authorisation" ).  The Company wishes to inform that the JOYSBIO Antigen Rapid Test Kit has, on 26 November 2020, received the Provisional Authorisation and the Provisional Authorisation shall remain valid until the HSA advises otherwise. The JOYSBIO Antigen Rapid Test Kit shall only be supplied to the healthcare institutions, private hospitals, medical clinics or clinical laboratories licensed under the Private Hospitals and Medical Clinics Act (PHMC Act) (Cap. 248) for use on their patients, for point-of-care testing and not for at-home testing. 
 
 
Pls see attached announcements for more details. 


 Useful To Me  Not Useful To Me
lailai
Elite
27-Nov-2020 11:55     
 
lailai About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Yeah shd exit when u got no confidence. Nobody ask u to stay. Your money your call lah.laugh

Sgvale      ( Date: 27-Nov-2020 11:48) Posted:

So many announcements but no sales figure. No confidence exited


eric998      ( Date: 27-Nov-2020 11:44) Posted:

anyone has info of the sales figures? 


 Useful To Me  Not Useful To Me


Sgvale
Supreme
27-Nov-2020 11:48     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		So many announcements but no sales figure. No confidence exited


eric998      ( Date: 27-Nov-2020 11:44) Posted:

anyone has info of the sales figures? 

 Useful To Me  Not Useful To Me
eric998
Supreme
27-Nov-2020 11:44     
 
eric998 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		anyone has info of the sales figures? 
 Useful To Me  Not Useful To Me
eric998
Supreme
27-Nov-2020 10:07     
 
eric998 About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		wait for ordesr and sales figures.. all these are paper news.. need to see real money coming in.. talk is free.. trade with care..

WBdisciple      ( Date: 27-Nov-2020 09:20) Posted:

TOTAL OF TWO ANNOUNCEMENTS last night by Biolidics 
https://www.biolidics.com/announcements
 
First one:  Biolidics&rsquo COVID-19 Antibody Test Kits obtained the relevant authorisation from Kementerian Kesehatan Republik Indonesia, which is the Ministry of Health in Indonesia, for it to be distributed and used in Indonesia  (the " Authorisation" ). The Authorisation remains valid until 25 November 2021 and the extension of its validity may be permissible should there be no undesirable events upon usage.
 
Second one:  Biolidics entered into a distribution agreement (the " JOYSBIO Agreement" ) with JOYSBIO (Tianjin) Biotechnology Co, Ltd,  a company incorporated in Tianjin, the People' s Republic of China (" JOYSBIO" ). JOYSBIO is the product owner of the medical device known as the  " SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold)"
 
Under the terms of the JOYSBIO Agreement, the Company has been appointed as the non-exclusive worldwide distributor of the JOYSBIO Antigen Rapid Test Kit for a duration of one year from the date of the JOYSBIO Agreement. In addition, under the terms of the JOYSBIO Agreement, among others, the Company shall automatically become the exclusive distributor of the JOYSBIO Antigen Rapid Test Kit in Singapore and the Philippines if the number of kits ordered by the Company reaches 100,000 units within 90 calendar days in Singapore and 1,000,000 units within 180 calendar days in the Philippines, from the date of the JOYSBIO Agreement (i.e. 26 November 2020), respectively.
 
The Company was appointed by JOYSBIO to prepare and submit applications to the Health Sciences Authority (" HSA" ) for provisional authorisation of the JOYSBIO Antigen Rapid Test Kit in Singapore (" Provisional Authorisation" ).  The Company wishes to inform that the JOYSBIO Antigen Rapid Test Kit has, on 26 November 2020, received the Provisional Authorisation and the Provisional Authorisation shall remain valid until the HSA advises otherwise. The JOYSBIO Antigen Rapid Test Kit shall only be supplied to the healthcare institutions, private hospitals, medical clinics or clinical laboratories licensed under the Private Hospitals and Medical Clinics Act (PHMC Act) (Cap. 248) for use on their patients, for point-of-care testing and not for at-home testing. 
 
 
Pls see attached announcements for more details. 

 Useful To Me  Not Useful To Me
Sgvale
Supreme
27-Nov-2020 09:32     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		StarShip no posting of sarcastic animation means possible. 0.50 also can

mattohoh      ( Date: 27-Nov-2020 09:28) Posted:

Hope so too

Sgvale      ( Date: 27-Nov-2020 09:21) Posted:

0.425 today
 Useful To Me  Not Useful To Me


mattohoh
Elite
27-Nov-2020 09:28     
 
mattohoh About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Hope so too

Sgvale      ( Date: 27-Nov-2020 09:21) Posted:

0.425 today
 Useful To Me  Not Useful To Me
WBdisciple
Elite
27-Nov-2020 09:25     
 
WBdisciple About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		With the HSA green light for the JOYSBIO  ANTIGEN test kit (distributed by BIOLIDCICS), more demand from Southeast Asia govt agencies?? 

Pls do your own DD.
 Useful To Me  Not Useful To Me
Sgvale
Supreme
27-Nov-2020 09:21     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		0.425 today
 Useful To Me  Not Useful To Me
WBdisciple
Elite
27-Nov-2020 09:20     
 
WBdisciple About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin
TOTAL OF TWO ANNOUNCEMENTS last night by Biolidics 
https://www.biolidics.com/announcements
 
First one:  Biolidics&rsquo COVID-19 Antibody Test Kits obtained the relevant authorisation from Kementerian Kesehatan Republik Indonesia, which is the Ministry of Health in Indonesia, for it to be distributed and used in Indonesia  (the " Authorisation" ). The Authorisation remains valid until 25 November 2021 and the extension of its validity may be permissible should there be no undesirable events upon usage.
 
Second one:  Biolidics entered into a distribution agreement (the " JOYSBIO Agreement" ) with JOYSBIO (Tianjin) Biotechnology Co, Ltd,  a company incorporated in Tianjin, the People' s Republic of China (" JOYSBIO" ). JOYSBIO is the product owner of the medical device known as the  " SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold)"
 
Under the terms of the JOYSBIO Agreement, the Company has been appointed as the non-exclusive worldwide distributor of the JOYSBIO Antigen Rapid Test Kit for a duration of one year from the date of the JOYSBIO Agreement. In addition, under the terms of the JOYSBIO Agreement, among others, the Company shall automatically become the exclusive distributor of the JOYSBIO Antigen Rapid Test Kit in Singapore and the Philippines if the number of kits ordered by the Company reaches 100,000 units within 90 calendar days in Singapore and 1,000,000 units within 180 calendar days in the Philippines, from the date of the JOYSBIO Agreement (i.e. 26 November 2020), respectively.
 
The Company was appointed by JOYSBIO to prepare and submit applications to the Health Sciences Authority (" HSA" ) for provisional authorisation of the JOYSBIO Antigen Rapid Test Kit in Singapore (" Provisional Authorisation" ).  The Company wishes to inform that the JOYSBIO Antigen Rapid Test Kit has, on 26 November 2020, received the Provisional Authorisation and the Provisional Authorisation shall remain valid until the HSA advises otherwise. The JOYSBIO Antigen Rapid Test Kit shall only be supplied to the healthcare institutions, private hospitals, medical clinics or clinical laboratories licensed under the Private Hospitals and Medical Clinics Act (PHMC Act) (Cap. 248) for use on their patients, for point-of-care testing and not for at-home testing. 
 
 
Pls see attached announcements for more details. 
 Useful To Me  Not Useful To Me
Sgvale
Supreme
27-Nov-2020 09:17     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		40% up today ?
 Useful To Me  Not Useful To Me
Starship
Supreme
27-Nov-2020 09:16     
 
Starship About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		The scriptwriter of this news article either has poor command of English or knew that the title does not accurately depict the facts (to put it nicely).

" obtained authorisation from the Indonesian health authorities for distribution and use in Indonesia" does not equate to " to be distributed and used in Indonesia"
The latter will only happen if someone there orders and buys the kits for use there.
 

WBdisciple      ( Date: 27-Nov-2020 08:08) Posted:

Biolidics' Covid-19 test kits to be distributed and used in Indonesia
THU, NOV 26, 2020 - 9:59 PM

CATALIST-LISTED medtech firm Biolidics on Thursday said its Covid-19 antibody test kits had, on Wednesday, obtained authorisation from the Indonesian health authorities for distribution and use in Indonesia.

The authorisation remains valid until Nov 25, 2021. The validity period may be extended " should there be no undesirable events upon usage" , Biolidics said.

The company noted that results from the test kits are not to be used for confirmatory testing or as the sole basis for diagnosis. The results have to be interpreted together with clinical presentation and are to be confirmed with supplementary testing.

It said shareholders and potential investors should note that policies relating to the diagnosis and detection of the Covid-19 virus and antibodies in various jurisdictions may change in response to developments in the Covid-19 situation, which is evolving rapidly.
 Useful To Me  Not Useful To Me
Sgvale
Supreme
27-Nov-2020 09:14     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		Past 0.40. Firework !!
 Useful To Me  Not Useful To Me
Sgvale
Supreme
27-Nov-2020 09:09     
 
Sgvale About Contact  Quote this Post!  
  x 0
  x 0

 Alert Admin 		30% up today?
 Useful To Me  Not Useful To Me
                                                         First   < Newer   421-440 of 4174   Older>   Last  



ShareJunction Version: 27 Nov 2020 ver- All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.